Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 8 | AXSM | Axsome Therapeutics, Inc. | MEXER◷ | 1,429 | — | — | +4.8% | Open the original filing on SEC.gov |
| Jun 5 | AXSM | Axsome Therapeutics, Inc. | AGRANT◆ | 1,721 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 5,537 | $223.39 | $1.2M | -15.8% | Open the original filing on SEC.gov |
| Jun 1 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 6,000 | $230.30 | $1.4M | -14.6% | Open the original filing on SEC.gov |
| May 29 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 6,000 | $233.46 | $1.4M | -12.7% | Open the original filing on SEC.gov |
| Feb 26 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 25,000 | $161.11 | $4M | -34.6% | Open the original filing on SEC.gov |
| Feb 23 | AXSM | Axsome Therapeutics, Inc. | MEXER◆ | 6,250 | — | — | — | Open the original filing on SEC.gov |
| Feb 23 | AXSM | Axsome Therapeutics, Inc. | MEXER | 6,250 | $4.95 | $30.9K | +9.5% | Open the original filing on SEC.gov |
| Feb 20 | AXSM | Axsome Therapeutics, Inc. | MEXER◆ | 12,485 | — | — | — | Open the original filing on SEC.gov |
| Feb 20 | AXSM | Axsome Therapeutics, Inc. | MEXER | 12,485 | $4.95 | $61.8K | +23.4% | Open the original filing on SEC.gov |
| Feb 10 | AXSM | Axsome Therapeutics, Inc. | MEXER◆ | 5,193 | — | — | — | Open the original filing on SEC.gov |
| Feb 10 | AXSM | Axsome Therapeutics, Inc. | MEXER | 5,193 | $8.02 | $41.6K | +10.8% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AXSM | Axsome Therapeutics, Inc. | PBUY | 488 | $127.40 | $62.2K | +1.0% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AXSM | Axsome Therapeutics, Inc. | PBUY | 287 | $127.30 | $36.5K | +0.6% | Open the original filing on SEC.gov |
| Sep 8, 2025 | AXSM | Axsome Therapeutics, Inc. | PBUY | 800 | $127.20 | $101.8K | +1.7% | Open the original filing on SEC.gov |
| Jun 6, 2025 | AXSM | Axsome Therapeutics, Inc. | AGRANT◆ | 1,429 | — | — | — | Open the original filing on SEC.gov |
| Jun 6, 2025 | AXSM | Axsome Therapeutics, Inc. | AGRANT◆ | 3,166 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 3,750 | $103.43 | $387.9K | -7.4% | Open the original filing on SEC.gov |
| May 27, 2025 | AXSM | Axsome Therapeutics, Inc. | SSELL◷ | 3,750 | $105.47 | $395.5K | -6.9% | Open the original filing on SEC.gov |
| May 20, 2025 | AXSM | Axsome Therapeutics, Inc. | SSELL | 3,000 | $107.49 | $322.5K | -5.3% | Open the original filing on SEC.gov |